Prevalence, Determinants, and Effect on Quality of Life of Freezing of Gait in Parkinson Disease
Santiago Perez‐Lloret(Université Fédérale de Toulouse Midi-Pyrénées), Olivier Rascol(Université Toulouse III - Paul Sabatier), Laurence Nègre‐Pagès(Pharmacochimie et Biologie pour le Développement), Pascal Derkinderen(Inserm), Philippe Damier(Inserm), Wassilios G. Meissner(Centre National de la Recherche Scientifique), François Tison(Institut des Maladies Neurodégénératives), Ludwig Schelosky(Kantonsspital Münsterlingen), A. Destée(Inserm), Arnaud Delval(Centre Hospitalier Universitaire de Lille)
Cited by 333
Related Papers
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
|Movement Disorders|2017|2.3k
The Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy
|Movement Disorders|2022|775
The natural history of multiple system atrophy: a prospective European cohort study
|The Lancet Neurology|2013|533
Targeting α-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerations
|The Lancet Neurology|2015|508
Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease
|Progress in Neurobiology|2015|472